B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

Genome studies of diffuse large B-cell lymphoma (DLBCL ... conferred an unfavorable prognosis, confirmed in the independent validation cohort. A gene expression profiling analysis showed that ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas ... Patients with lymphoma whose disease has returned after several lines of therapy have a very poor prognosis, with ...

In the article that accompanies this editorial, Bartlett et al 11 present the results of ECHELON-3, a phase III trial comparing brentuximab vedotin + lenalidomide + rituximab (BV + Len + R) with ...

Currently, prognosis in patients with FL is assessed using clinical scores such as the Follicular Lymphoma International Prognostic Index (FLIPI), which incorporates age, disease stage ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas ... Patients with lymphoma whose disease has returned after several lines of therapy have a very poor prognosis, with ...

While the trial was not designed to evaluate efficacy, Ghobadi and colleagues said that responses were observed across B-cell lymphoma histologies among those treated with the combination ...